Literature DB >> 28607481

Cell cycle: Division enzyme regulates metabolism.

Abigail S Krall1, Heather R Christofk1.   

Abstract

Mesh：

Year:  2017        PMID： 28607481     DOI： 10.1038/nature22504

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes.

Authors:  Benjamin P Tu; Andrzej Kudlicki; Maga Rowicka; Steven L McKnight
Journal:  Science       Date:  2005-10-27       Impact factor: 47.728

2.  Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity.

Authors:  Zheng Chen; Elizabeth A Odstrcil; Benjamin P Tu; Steven L McKnight
Journal:  Science       Date:  2007-06-29       Impact factor: 47.728

3.  The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.

Authors:  Haizhen Wang; Brandon N Nicolay; Joel M Chick; Xueliang Gao; Yan Geng; Hong Ren; Hui Gao; Guizhi Yang; Juliet A Williams; Jan M Suski; Mark A Keibler; Ewa Sicinska; Ulrike Gerdemann; W Nicholas Haining; Thomas M Roberts; Kornelia Polyak; Steven P Gygi; Nicholas J Dyson; Piotr Sicinski
Journal:  Nature       Date:  2017-06-07       Impact factor: 49.962

4.  Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.

Authors:  Dimitrios Anastasiou; George Poulogiannis; John M Asara; Matthew B Boxer; Jian-kang Jiang; Min Shen; Gary Bellinger; Atsuo T Sasaki; Jason W Locasale; Douglas S Auld; Craig J Thomas; Matthew G Vander Heiden; Lewis C Cantley
Journal:  Science       Date:  2011-11-03       Impact factor: 47.728

Review 5.  Cyclins and cdks in development and cancer: a perspective.

Authors:  Amit Deshpande; Peter Sicinski; Philip W Hinds
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 6.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

7.  Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Authors:  Matt I Gross; Susan D Demo; Jennifer B Dennison; Lijing Chen; Tania Chernov-Rogan; Bindu Goyal; Julie R Janes; Guy J Laidig; Evan R Lewis; Jim Li; Andrew L Mackinnon; Francesco Parlati; Mirna L M Rodriguez; Peter J Shwonek; Eric B Sjogren; Timothy F Stanton; Taotao Wang; Jinfu Yang; Frances Zhao; Mark K Bennett
Journal:  Mol Cancer Ther       Date:  2014-02-12       Impact factor: 6.261

8.  Phosphofructokinase 1 glycosylation regulates cell growth and metabolism.

Authors:  Wen Yi; Peter M Clark; Daniel E Mason; Marie C Keenan; Collin Hill; William A Goddard; Eric C Peters; Edward M Driggers; Linda C Hsieh-Wilson
Journal:  Science       Date:  2012-08-24       Impact factor: 47.728

9.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

Review 10.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728
View more
  6 in total

1.  Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design, Synthesis, In Vitro, and In Vivo Anticancer Evaluation.

Authors:  Somaya A Abdel-Rahman; Ashraf K El-Damasy; Ghada S Hassan; Emad I Wafa; Sean M Geary; Azza R Maarouf; Aliasger K Salem
Journal:  ACS Pharmacol Transl Sci       Date:  2020-08-27

Review 2.  Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.

Authors:  Rebecca A Sager; Sarah J Backe; Elham Ahanin; Garrett Smith; Imad Nsouli; Mark R Woodford; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Nat Rev Urol       Date:  2022-03-09       Impact factor: 16.430

3.  Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines.

Authors:  Heidrun Karlic; Florian Haider; Roman Thaler; Silvia Spitzer; Klaus Klaushofer; Franz Varga
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

4.  Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells.

Authors:  Erika Terzuoli; Ginevra Nannelli; Maria Frosini; Antonio Giachetti; Marina Ziche; Sandra Donnini
Journal:  Oncotarget       Date:  2017-08-24

5.  Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.

Authors:  Shi-Bing Li; Yan-Yan Liu; Li Yuan; Ming-Fang Ji; Yu-Ming Zheng; Zhi-Qiang Ling; Jian-Hua Sui; Mu-Sheng Zeng; Ao Zhang; Hui-Yu Li; Lin-Quan Tang; Shuo-Gui Fang; Hua Zhang; Shan Xing; Man-Zhi Li; Qian Zhong; Shao-Jun Lin; Wan-Li Liu; Peng Huang; Yi-Xin Zeng
Journal:  EMBO Mol Med       Date:  2020-07-12       Impact factor: 12.137

6.  Synthetase of the methyl donor S-adenosylmethionine from nitrogen-fixing α-rhizobia can bind functionally diverse RNA species.

Authors:  Marta Robledo; Natalia I García-Tomsig; Ana M Matia-González; Fernando M García-Rodríguez; José I Jiménez-Zurdo
Journal:  RNA Biol       Date:  2020-10-10       Impact factor: 4.652
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.